Structure of the fanconi anaemia monoubiquitin ligase complex by Shakeel, Shabih et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Structure of the fanconi anaemia monoubiquitin ligase complex
Citation for published version:
Shakeel, S, Rajendral, E, Alcón, P, O’Reilly, FJ, Chorev, DS, Maslen, S, Degliesposti, G, Russo, CJ, He, S,
Hill, CH, Skehel, JM, Scheres, SHW, Patel, KJ, Rappsilber, J, Robinson, CV & Passmore, LA 2019,
'Structure of the fanconi anaemia monoubiquitin ligase complex', Nature, vol. 575, pp. 234-237.
https://doi.org/10.1038/s41586-019-1703-4
Digital Object Identifier (DOI):
10.1038/s41586-019-1703-4
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Nature
Publisher Rights Statement:
This is the accepted version of the following article: Shakeel, S., Rajendra, E., Alcón, P. et al. Structure of the
Fanconi anaemia monoubiquitin ligase complex. Nature 575, 234–237 (2019). https://doi.org/10.1038/s41586-
019-1703-4, which has been published in final form at https://www.nature.com/articles/s41586-019-1703-
4#citeas
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 22. Sep. 2020
  1 
Structure of the Fanconi anaemia monoubiquitin ligase complex 
Shabih Shakeel1,5, Eeson Rajendra1,5, Pablo Alcón1, Francis O’Reilly2, Dror S. Chorev3, Sarah Maslen1, 
Gianluca Degliesposti1, Christopher J. Russo1, Shaoda He1, Chris H. Hill1, J. Mark Skehel1, Sjors H. W. 
Scheres1, Ketan J. Patel1, Juri Rappsilber2,4, Carol V. Robinson3 & Lori A. Passmore1* 
1MRC Laboratory of Molecular Biology, Cambridge UK. 
2Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany. 
3Physical and Theoretical Chemistry Laboratory, University of Oxford, Oxford, UK. 
4Wellcome Centre for Cell Biology, University of Edinburgh, Edinburgh, UK. 
5These authors contributed equally: Shabih Shakeel, Eeson Rajendra 
Correspondance :  passmore@mrc-lmb.cam.ac.uk 
The Fanconi anaemia (FA) pathway repairs DNA damage caused by endogenous and 
chemotherapy-induced DNA crosslinks, and responds to replication stress1,2. 
Genetic inactivation of this pathway impairs development, prevents blood production 
and promotes cancer1,3. The key molecular step in the FA pathway is the 
monoubiquitination of a pseudosymmetric heterodimer of FA group I protein 
(FANCI)–FA group D2 protein (FANCD2)4,5 by the FA core complex—a megadalton 
multiprotein E3 ubiquitin ligase6,7. Monoubiquitinated FANCD2 then recruits 
enzymes to remove the DNA crosslink or to stabilize the stalled replication fork. A 
molecular structure of the FA core complex would explain how it acts to maintain 
genome stability. Here we reconstituted an active, recombinant FA core complex, and 
used cryo-electron microscopy and mass spectrometry to determine its structure. The 
FA core complex comprises two central dimers of the FA group B protein (FANCB) 
and FA-associated protein of 100 kDa (FAAP100) subunits, flanked by two copies of 
the RING finger protein, FA complementation group L protein (FANCL). These two 
heterotrimers act as a scaffold to assemble the remaining five subunits, resulting in 
an extended asymmetric structure. Destabilization of the scaffold would disrupt the 
entire complex, resulting in a non-functional FA pathway. Thus, the structure 
provides a mechanistic basis for the low numbers of patients with mutations in 
FANCB, FANCL and FAAP100. Despite a lack of sequence homology, FANCB and 
FAAP100 adopt similar structures. The two FANCL subunits are in different 
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conformations at opposite ends of the complex, suggesting that each FANCL has a 
distinct role. This structural and functional asymmetry of RING finger domains may 
be a general feature of E3 ligases. The cryo-EM structure of the FA core complex 
provides a foundation for a detailed understanding of its E3 ubiquitin ligase activity 
and DNA interstrand crosslink repair. 
The FA core complex is composed of eight stably-associated subunits: FANCA, 
FANCB, FANCC, FANCE, FANCF, FANCG, FANCL and FAAP1006. FANCL contains 
a RING-finger domain which acts as the E3 ubiquitin ligase. It associates with FANCB 
and FAAP100 to form a catalytic module6,8; a low-resolution negative-stain electron 
microscopy study suggested that, in the absence of the other subunits, this is a symmetric 
dimer of FANCB–FANCL–FAAP100 heterotrimers9. FANCA and FANCG are proposed 
to act as a chromatin-targeting module, whereas FANCC, FANCE and FANCF form a 
substrate-recognition module6,8,10,11. Despite the central role of the FA core complex in 
DNA repair, we lack a molecular understanding of how FANCL incorporates into the 
complex to perform site-specific monoubiquitination of the FANCI–FANCD2 substrate 
and how mutation disrupts the function of the complex12. 
To determine the structure of the FA core complex, we overexpressed all eight 
subunits from Gallus gallus (chicken) on a single baculovirus in insect cells, which enabled 
us to purify an intact, recombinant complex (Fig. 1a). The purified complex specifically 
monoubiquitinated FANCD2 but not FANCI in vitro (Extended Data Fig. 1), similar to the 
native chicken complex6. 
To investigate the molecular basis of subunit association, we imaged this 
recombinant FA core complex using cryo-EM. This revealed an elongated structure, about 
25 nm in length (Fig. 1b, Extended Data Fig. 2a). We determined a 3D reconstruction of 
the FA core complex at an overall resolution of 4.2 Å (Extended Data Fig. 2b–e, Extended 
Data Table 1). The peripheral regions were less well resolved than the central core, possibly 
owing to conformational flexibility. In agreement with this reconstruction, we detected 
structural variations using multi-body refinement13, including a continuum of 
conformational movement of the top and base regions (Extended Data Fig. 2f, 
Supplementary Videos 1, 2). Particle subtraction followed by focused classification and 
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refinement14 generated separate, improved reconstructions of the top and base regions 
(Fig. 1c, Extended Data Fig. 2g, h and Supplementary Video 3). 
Our map of the complete FA core complex was of sufficient resolution to dock 
existing structures and to resolve secondary structure elements (Extended Data Fig. 2i). 
We fit two previously determined high-resolution structures (FANCL15 and part of 
FANCF16) into the map, accounting for about 12% of the entire mass of the complex. Most 
subunits do not have substantial homology to proteins of known structure (Extended Data 
Table 2), so we modelled  -helices and  -strands into the remainder of the map. To 
determine which subunits these  -helices and  -strands belong to, we required additional 
data. 
Next, we purified subcomplexes and imaged them using cryo-EM. By comparing 
the 2D class averages to the complete FA core complex, we identified regions 
corresponding to specific subunits (Extended Data Fig. 3a–c). Removal of FANCA did not 
substantially change the class averages. This suggested that FANCA may be 
conformationally heterogeneous and blurred out in reconstructions, or it may dissociate or 
denature during cryo-EM specimen preparation. The base was absent in a complex of 
FANCA, FANCG, FANCB, FANCL and FAAP100, suggesting that the base probably 
contains the substrate-recognition module (FANCC, FANCE and FANCF). The partially 
disordered arm that extends from the central part of the complex is probably FANCG 
because this density is lost when FANCG is removed from a FANCB–FANCL–FAAP100 
complex. Finally, 2D classes of the catalytic module (FANCB, FANCL and FAAP100) 
resemble the middle region of the FA core complex. 
We also studied the structure of the FA core complex using non-covalent native 
mass spectrometry (Extended Data Fig. 3d, e). During ionization, the FANCE subunit tends 
to dissociate and subcomplexes are formed, providing information on subunit 
stoichiometry and protein–protein interactions. The largest complex (808 kDa) that we 
detected in native mass spectrometry contains seven of the eight different subunits, 
including two copies of FANCB, FANCL and FAAP100, and a single copy of each of the 
remaining subunits. This agrees with the subunit stoichiometries of a purified native FA 
core complex6. FANCB, FANCL and FAAP100 were present in most of the subcomplexes 
  4 
identified by native mass spectrometry (Extended Data Fig. 3d), suggesting that they form 
a central core. 
To identify residues in close proximity, we performed crosslinking mass 
spectrometry (Fig. 1d, Extended Data Fig. 4). This revealed 834 inter- and intra-molecular 
crosslinks, with 40% of these located in FANCB, FANCL and FAAP100. This is consistent 
with these three subunits forming an intimate complex. By combining the crosslinking 
mass spectrometry data showing which residues are in close proximity with the subunit 
assignment from subcomplexes, the subunit stoichiometry from native mass spectrometry, 
homology modelling and secondary structure predictions, we generated models for all FA 
core complex subunits except FANCA (Fig. 1e, Extended Data Fig. 5a–d, Extended Data 
Table 1, 2, Supplementary Video 4, Methods). 
A dimer of FANCB–FAAP100 heterodimers is located in the middle region of the 
structure (Fig. 2). Two pairs of long  -helices (coiled coils) connect central  -strands and 
helical bundles with peripheral densities (Fig. 2b, c). Crosslinking mass spectrometry and 
modelling showed that each coiled coil is probably composed of  -helices from FANCB 
and FAAP100 (Extended Data Fig. 5e, f). At the peripheral ends of the coiled coils, we 
identified pairs of  -propellers, each containing a  -propeller from the N-terminal regions 
of FANCB and FAAP100 (Fig. 2d). We could differentiate the two  -propellers on the 
basis of crosslinks: the FANCB  -propeller is near the coiled coil, whereas the FAAP100 
 -propeller is close to the ELF domain of FANCL. Unexpectedly, despite the lack of 
sequence homology, FANCB and FAAP100 share markedly similar overall structures and 
domain organizations (Fig. 2e). 
A homology model of FANCL, including the ELF, URD and RING finger 
domains15, fits into the base of the complex (Fig. 3a, b) but the relative orientations of the 
individual domains are different compared with the crystal structure (Extended Data Fig. 
4b). By contrast, only the ELF domain could be placed into the second copy of FANCL at 
the top of the complex (Fig. 3c). Hydrogen–deuterium exchange mass spectrometry (HDX-
MS) confirmed that FANCL interacts with the FANCB–FAAP100 coiled coil (Extended 
Data Fig. 6). 
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FANCG contains tetratricopeptide repeats (TPRs) (Fig. 3d, e) and crosslinks to the 
central FANCB–FAAP100 dimer (Fig. 1d), and is required for FANCA association 
(Extended Data Fig. 3b). Of note, there is a channel between FANCG and the catalytic 
module (Fig. 1e). FANCA, which is absent in the maps, is probably peripheral to FANCG, 
and possibly located in the blurred density visible in 2D class averages (indicated by 
asterisks in Fig. 1b; Extended Data Fig. 5d). The large number of crosslinks between 
FANCA and FANCG are consistent with their proximity (Fig. 1d). 
The substrate-recognition module (FANCC, FANCE and FANCF), located in the 
base, comprises an arc of  -helices (Fig. 3f). FANCF occupies a central position within 
the arc. Crosslinking mass spectrometry showed that the FANCL RING finger and ELF 
domain contact FANCE and FANCF, the FANCL URD domain contacts FANCC and 
FANCE, and the FANCC C-terminal region and FANCE are in close proximity. Native 
mass spectrometry also showed direct contact between FANCE and FANCF (Extended 
Data Fig. 3d). 
We also determined a structure of a subcomplex, present at a lower abundance in 
our sample, at an overall resolution of 4.6 Å (Extended Data Fig. 7a–d). This subcomplex 
was symmetric but the map did not improve on application of C2 symmetry. We therefore 
implemented a local symmetry algorithm in Relion for averaging the two halves of the 
subcomplex map (Methods, Extended Data Fig. 7e, f). This symmetric structure revealed 
an assembly comprising two copies of each of FANCB, FANCL, FAAP100 and FANCG 
(Extended Data Fig. 8a–c, Supplementary Video 5). It is unclear whether this subcomplex 
has a functional role in vivo or whether it is an assembly intermediate. In both copies of 
FANCL, the URD and RING finger domains have weak density or are not visible, similar 
to the top FANCL (FANCLtop) in the full, asymmetric FA core complex. 
Comparison of subcomplex and FA core complex structures suggests that the 
substrate recognition module alters the relative orientations of the  -propellers and coiled 
coil in the base (Fig. 2d, Supplementary Video 6). This disrupts the symmetry of the 
catalytic module in the complete FA core complex, provides a binding site in the base for 
the URD and RING finger domains of FANCL and probably disrupts docking of a second 
(symmetric) copy of FANCG onto the middle region owing to steric clashes (Extended 
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Data Fig. 8d). These structural alterations may be transmitted to the top region to prevent 
the binding of a second substrate-recognition module, consistent with allosteric coupling 
proposed previously9. In agreement with this, a purified substrate recognition module did 
not readily associate with the symmetric subcomplex in vitro to form the asymmetric FA 
core complex (Extended Data Fig. 8e, f), suggesting that in vivo assembly is required. 
Dimerization is required for the activity of other E3 ligases, including the Rad18, 
RNF8 and CHIP homodimers17–19 and the BRCA1–BARD1 and Ring1b–Bmi1 
heterodimers20,21. These contain two RING finger–U-box domains arranged in an 
asymmetric manner with only a single functional E2 binding site. Notably, the activity of 
multi-subunit cullin–RING finger E3 ligases is stimulated by dimerization22,23. Thus, 
structural and functional asymmetry appear to be a common feature of E3 ligases but the 
spatial separation of the FANCL RING fingers in the FA core complex is unusual 
(Extended Data Fig. 9a, b). Like other dimeric RING finger E3s, one RING finger (in the 
FANCL subunit at the base (FANCLbase)) of the FA core complex may have a structural 
role in promoting substrate binding along with FANCE10,11,24,25, whereas the other 
(FANCLtop) may be the active E3 that promotes ubiquitin transfer26 to FANCD2 (Fig. 
3g) within the structural state we observe. The FANCI–FANCD2 substrate is also an 
asymmetric dimer. Thus, each of the two FANCL RING finger domains could 
monoubiquitinate one of the substrate proteins. Nevertheless, this purified complex does 
not monoubiquitinate FANCI, so an additional activation step might be required. Substrate 
binding is not required to activate the E3 ligase activity (Extended Data Fig. 9c, d). 
The majority of FA-complex mutations detected in patients with FA result in 
protein truncation and are found in the structural periphery of the FA core complex27 
(Extended Data Fig. 9e). Residual monoubiquitin ligase activity is still present after 
deletion of peripheral subunits in cells6,8 and in vitro (Extended Data Fig. 9f), indicating 
a partially functioning core complex. By contrast, deletion of FANCB, FANCL or 
FAAP100, which comprise the catalytic module and the structural scaffold for the 
complex, eliminates this residual activity6,8. Patients with FA who carry mutations in 
FANCB or FANCL are severely afflicted, and we predict that FANCB missense mutations 
(L43S, P230S, L329P and L676P) disrupt stability of the catalytic module (indicated by 
asterisks in Extended Data Fig. 4a). Together, these data provide genetic and clinical 
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support that mutations in the catalytic module result in disruption of the FA core complex 
structure. By contrast, mutations in the periphery do not prevent complex formation and 
may be better tolerated. 
In sum, our data provide a structural model for the FA core complex, enabling an 
interpretation of the molecular pathophysiology of FA.The reconstituted system we 
describe will also enable further mechanistic questions to be addressed, including precisely 
how this large complex functions as a DNA damage-inducible monoubiquitin ligase. 
 
 
Fig. 1 | Overall structure of the FA core complex. a, SDS–PAGE analysis of purified 
FA core complex with subunits and molecular weight markers indicated. FANCC carries 
  8 
a 2× Strep II tag on its C terminus (FANCC–SII). This purification was repeated more than 
three times with similar results. For gel source data, see Supplementary Fig. 1. b, Selected 
2D reference-free class averages of the FA core complex. One class appears to be 
symmetric (labelled). Asterisks mark disordered density extending from the side of the 
complex that does not align well. c, Focused classification and refinement on the top and 
base regions, and multibody refinement on the middle region resulted in three independent 
cryo-EM maps that are shown separately, in three different shades of grey. d, Crosslinking 
mass spectrometry revealed 834 crosslinks (1% false discovery rate) between residues that 
are in close proximity. Intermolecular crosslinks are shown, coloured by interacting 
regions. e, Model of FA core complex (cartoon representation) fitted into the EM density 
(isosurface representation with transparency). Map and model are coloured by assigned 
subunits. The green star marks a channel with diameter approximately 23 Å. 
 
 
Fig. 2 | The molecular scaffold of the FA core complex includes a dimer of FANCB–
FAAP100 heterodimers. a, Surface representation of the FA core complex model, 
highlighting FANCB and FAAP100. FANCB, orange; FAAP100, yellow; regions where 
we are unable to distinguish FANCB and FAAP100, yellow–orange. b–d, Models of 
FANCB and FAAP100 subunits in cartoon representation placed into the cryo-EM map. 
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In b, a black oval marks the pseudo two-fold symmetry axis. The two symmetry-related 
copies are shown in different shades of yellow in the model. In d, cones indicate the 
orientations of the central pores of the b-propellers and the angles between them are shown. 
e, Proposed domain organization of FANCB and FAAP100, showing their structural 
similarity. 
 
 
Fig. 3 | Asymmetric dimerization in the FA core complex. a–c, Models of FANCL in 
the FA core complex. a, Surface representation of the FA core complex model, highlighting 
the two copies of FANCL. b, c, Models of FANCLbase and FANCLtop subunits in cartoon 
representation are shown fitted in the cryo-EM map. Density for the URD and RING 
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domains is not well defined in the top copy (c). d–f, Models of FANCG and the substrate 
recognition module. d, Surface representation of the FA core complex model highlighting 
FANCG and the substrate-recognition module (FANCC–FANCE–FANCF). e, f, Models 
of FANCG TPR domain (e) and the substrate-recognition module (f) are shown fitted into 
the cryo-EM map. The crystal structure of FANCF could be assigned and the N and C 
termini of the model are indicated. The first helix (N to *) was not present in the crystal 
structure. Since all three subunits of the substrate recognition module are substantially 
helical, it was not possible to assign the remaining helices of the base to individual subunits. 
g, Model for monoubiquitination of FANCD2 by the FA core complex. The major motions 
detected in multi-body refinement are indicated with grey arrows. 
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METHODS 
Cloning, expression and purification 
cDNAs encoding full length G. gallus (Gg) FANCA, FANCB, FANCC, FANCE, FANCF, 
FANCG, FANCL and FAAP100 were synthesized (GeneArt). FANCC contained a C-
terminal extension with a 3C protease site and double Strep II tag. For protein expression, 
all genes were cloned into the MultiBac expression system and constructs were generated 
as previously described28. In brief, to make gene expression cassettes, FANCA and 
FANCG were subcloned via BamHI and XbaI into pACEBac1; FANCC, FANCE, FANCF 
and FAAP100 were subcloned via XhoI and KpnI into pIDS; and FANCB and FANCL 
were subcloned via BamHI and XbaI into pIDC. Gene cassettes were then sequentially 
subcloned as BstXI–ICeuI or BstXI–PISceI fragments into ICeuI or PISceI sites to generate 
pACEBac1-FANCA-FANCG, pIDS-FANCC-3C-2×StrepII-FANCE-FANCF, and pIDS-
FAAP100-FANCB-FANCL. The spectinomycin antibiotic resistance cassette of pIDS-
FAAP100-FANCB-FANCL was substituted with the kanamycin antibiotic resistance 
cassette of pIDK as a SnaBI-PI-SceI fragment to generate pIDK-FAAP100-FANCB-
FANCL. 
pACEBac1-FANCA-FANCG, pIDK-FAAP100-FANCB-FANCL and pIDS-FANCC-3C-
2×StrepII-FANCE-FANCF were fused using Cre recombinase (NEB) to generate a single 
vector (gentamicin, spectinomycin and kanamycin resistant) containing a single copy of 
each gene (FA core complex) used to make protein for the initial data collection. All 
constructs were confirmed by restriction digest analysis, PCR and sequencing. 
For subsequent protein preparations, A-G-B-L-100-C-E-F, A-G-B-L-100, G-B-L-100 and 
C-E-F complexes (letters indicate the FANC family members) were prepared using a 
modified BiGBac system as described previously29,30. The individual genes were PCR 
amplified for cloning into pBIG vectors from pACEBac1, pIDC or pIDS vectors. 
Sequences encoding 2×Strep II tag and 3C protease site were included on FANCC. If 
FANCC was not present, the tag sequence was added to FANCB. The combined vector 
carrying the FA core complex or subcomplex was transformed into EMBacY cells to 
generate a bacmid. Bacmid DNA was transfected into Sf9 cells and virus was passaged 
twice in the same cell line before large-scale infection in Sf9 cells. Infected cells were 
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collected when cell growth arrested. Sf9 cells were obtained from Oxford Expression 
Technologies, catalogue no. 600100 (negative for mycoplasma, identity not independently 
authenticated by us). 
Cells were lysed by sonication in lysis buffer (100 mM HEPES pH 8.0, 300 mM NaCl, 1 
mM TCEP, 5% glycerol, EDTA-free protease inhibitor, 5 mM benzamidine hydrochloride 
and 100 U ml 1 benzonase). Clarified cell lysate was incubated with streptavidin beads 
(GE Healthcare) for 1 h followed by wash with lysis buffer. Proteins were eluted in elution 
buffer (100 mM HEPES pH 8.0, 300 mM NaCl, 1 mM TCEP, 5% glycerol and 8 mM 
desthiobiotin). Further purification was performed by HiTrap Heparin HP affinity column 
(GE Healthcare) using a linear gradient of NaCl from concentration of 150 mM to 1 M in 
50 mM HEPES pH 8.0, 1 mM TCEP, over 22 column volumes. For FA core complex, this 
was followed by anion-exchange chromatography (MonoQ, GE Healthcare) in the same 
buffer using a linear gradient of NaCl from concentration of 150 mM to 1 M over 20 
column volumes. The final buffer for purified FA core complex and subcomplexes was 50 
mM HEPES pH 8.0, ~500 mM NaCl, 1 mM TCEP. 
Ubiquitination assay 
Ubiquitination assays were performed as described previously6,31. In brief, a reaction 
volume of 20 µl contained 75 nM E1 (Boston Biochem), 1 µM E2 (GgUBE2T), 0.25 µM 
E3 (FA core complex), 1 µM substrate (His-GgFANCI, GgFANCIK525R, His-
GgFANCD2, GgFANCD2K563R), 50 µM 5 -flapped DNA and 20 µM haemagglutinin 
(HA)–ubiquitin (Boston Biochem). For ubiquitin discharge assays, concentrations of 125 
nM E1 (Boston Biochem), 5 µM E2 (GgUBE2T), 1.5 µM E3 (FA core complex) and 50 
mM free lysine (instead of substrate) were used. The 0.25 µM E3 enzyme concentration is 
based on the FANCL subunit, estimated by comparing the amount of FANCL in FA core 
complex and subcomplexes against purified FANCL of known concentration on SDS–
PAGE. The reaction buffer was 50 mM HEPES pH 8.0, 64 mM NaCl, 4% glycerol, 5 mM 
MgCl2, 2 mM ATP and 0.5 mM DTT. The reaction was incubated at 30 °C for 90 min, 
stopped by adding NuPAGE LDS sample buffer (ThermoFisher) and run on an SDS 
polyacrylamide gel (3–8% NuPAGE Tris-acetate). Samples were analysed by Coomassie 
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staining or by western blot using a HA antibody (Santa Cruz Biotechnology). All assays 
were performed independently three times. 
Electron microscopy 
Protein complexes were vitrified by applying 3–3.5  l purified protein (~1  M) to 
UltraAuFoil R1.2/1.3 grids (Quantifoil)32 with a thin continuous carbon support layer (for 
initial FA core complex data set) or in unsupported ice (for final FA core complex data set 
and subcomplexes) that had been made hydrophilic using an argon:oxygen plasma, blotting 
for 2.5, 3 or 4.5 s at 4 °C with relative humidity of 100% and plunging into liquid ethane 
using a Vitrobot Mark IV (FEI). 
Cryo-EM data were collected on a FEI Titan Krios transmission electron microscope 
operated at 300 keV acceleration voltage using EPU automated data collection software. 
An initial data set was collected on a Falcon II detector at 47,000× nominal magnification 
with a pixel size of 1.774 Å per pixel. The final data for FA core complex (Extended Data 
Table 1) were collected on a Falcon III detector in counting mode at 75,000× nominal 
magnification, and pixel size of 1.04 Å (MRC LMB) or 1.085 Å (eBIC). The subcomplexes 
G-B-L-100-C-E-F, A-G-B-L-100 and G-B-L-100 were imaged at 59,000× nominal 
magnification on a Falcon III detector in integrating mode. B-L-100 data were collected at 
47,000× on a Falcon II detector in integrating mode. 
Cryo-EM image processing 
Image processing was performed in Relion (v.2 and v.3.0-beta)33–35, and Relion wrappers 
were used for external programs except for EMAN236. For all data sets, whole-frame 
alignment was performed using MotionCor237, and contrast transfer function parameters 
were estimated using gCTF38. 3D maps were post-processed to automatically estimate and 
apply the B-factor and to determine the resolution by Fourier shell correlation (FSC) 
between two independent half datasets using 0.143 criterion39. Local resolution was 
estimated using ResMap40. 
Initial model 
The initial FA core complex data set was processed in Relion v.2. Particles were picked 
manually from a few micrographs, and used for 2D class averaging with a box size of 390 
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pixels. The resulting 2D class averages were used to pick particles from all micrographs 
using template-matching in Relion's autopicker. After 2D classification of the auto-picked 
particles, selected classes were used to make an initial 3D model in EMAN236. This initial 
model was used for subsequent 3D classification and refinement in Relion. 
Refinement 
The map generated from the Falcon II data set was used during the first round of 3D 
classification with particles from the Falcon III data set of FA core complex. The data sets 
from MRC LMB and eBIC were initially processed separately, to generate separate 3D 
reconstructions. The pixel size of eBIC data was determined using the 2.35 Å spacing from 
the gold foil images collected under same imaging conditions as the sample data. The eBIC 
micrographs were then rescaled to the pixel size of LMB data and CTF was re-estimated, 
and all datasets were merged. 
The FA core complex map was divided into three bodies: body 1 (middle region), body 2 
(base region) and body 3 (top region). Bodies 2 and 3 were rotated relative to 1 because 
body 1 (middle) region appears to be the most rigid (Extended Data Fig. 2f). Sigma angles 
of 10 and sigma offset of 2 were used during refinement. Multibody refinement13 was 
continued from the last iteration of consensus refinement. The middle region was best 
resolved with an overall resolution of 4.4 Å whereas the top and base were ~7 Å resolution. 
To estimate the flexibility in the FA core complex we performed principal component 
analysis on the optimal orientations of all the bodies for all particle images in the dataset 
using relion_flex_analyse13. We rendered videos for principal components 1 and 2 as these 
described ~30% of the variance in the rotations and translations. 
Per-particle CTF refinement and beam tilt estimation were performed by dividing the 
datasets into individual data collection sessions and processing in a bigger box of 586 
pixels, followed by further refinement35. The resolution of the maps for the top and base 
regions of the complete complex were further improved by performing focused 
classification with signal subtraction14 followed by refinement (Extended Data Fig. 2g, h). 
The overall resolution is likely limited by heterogeneity. A regularization T-value of 5 was 
used during 3D refinement to boost the contribution of higher spatial frequencies41, to 
improve the quality of the map to aid in model building. 
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The subcomplexes were processed up to 2D classification as there were not enough 
different views to generate a 3D map. 
Local symmetry averaging 
Cryo-EM structure determination by single-particle analysis relies on the reduction of noise 
through averaging over multiple copies of extremely noisy projection images of individual 
macromolecular complexes. For symmetric complexes, for example, for homo-multimers 
or for icosahedral virus capsids, additional averaging can be performed by imposing point-
group symmetry on the reconstruction. Because each projection image of a symmetrical 
object provides multiple views of the asymmetric unit, compared to asymmetric 
complexes, the same number of images will yield a better reconstruction, or fewer images 
are needed to obtain a reconstruction of the same quality. Therefore, point-group symmetry 
averaging is commonly employed in single-particle analysis refinement programs. 
The FA subcomplex described here, does not obey overall point-group symmetry, but still 
contains multiple, potentially identical, subcomplexes. We call this local symmetry. 
Averaging over locally symmetric subcomplexes in cryo-EM single-particle analysis has 
previously been performed to improve reconstructions after completion of the refinement 
process, for example on the subunits of triangulation number T  1 virus capsids42,43. 
However, local symmetry averaging has the potential to improve the reconstruction at 
every stage of the iterative refinement process. Better reconstructions during refinement 
will lead to better alignments, and hence a better final reconstruction. Therefore, we 
implemented a local symmetry averaging approach inside the relion_refine program. This 
approach has conceptual similarities to imposing non-crystallographic symmetry (NCS) in 
X-ray crystallography44. 
This new implementation within Relion3.0 allows the user to define an arbitrary number 
of groups, each with an arbitrary number of assumed identical subcomplexes. For each 
group, the user provides a mask around one member of the group, as well as 3D 
transformation matrices (expressed as three Euler angles and three translations in x, y and 
z) in real space to superimpose that member onto each of the other members in the group. 
This information is expressed in a Relion-style STAR file, which is passed using the–
local_symmetry command line option to the relion_refine program. A helper program to 
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find and optimize the 3D transformation matrices, relion_localsym, was also implemented. 
To minimize artefacts in Fourier space, the edges of the masks should be kept soft, that is, 
they should gradually change from zero to one over multiple real-space pixels. 
Our new implementation allows local symmetry averaging in both 3D classifications and 
3D refinements, and works with 2D projection images as well as 3D images, such as sub-
tomograms. At every step of the expectation-maximization algorithm, local symmetry is 
applied according to the masks and transformations defined in the STAR file. This 
symmetrization is performed after the maximization step in real space. As such, the signal-
to-noise gain that arises from the additional averaging is not considered when calculating 
the FSC between the two independent half-reconstructions in 3D auto-refinement, or when 
calculating the signal from the power of the reconstruction in 3D classification. Therefore, 
in cases of local symmetry, it may be advantageous to increase the empirical regularization 
T-value,–tau2_fudge, to account for the expected gain in signal during the refinement. 
When doing so, care should be taken not to overfit the data by using a too high T-value. 
Calculation of a final FSC curve using Relion’s post-processing program will lead to a 
realistic resolution estimate. However, care should be taken to use soft-edged masks for 
the local symmetrization, as the real-space mask operations may lead to artefacts in the 
Fourier-based resolution assessment. 
Another note of caution considers the assumption that all the members of each of the local 
symmetry groups are identical. Since, by definition, the complex does not obey point group 
symmetry, this assumption can never be entirely true. At the very least, some of the 
subcomplex interfaces will be chemically different, whereas in worst-case scenarios 
biologically relevant conformational differences may exist within the members of each 
group. Imposing (local) symmetry on objects that are not identical will lead to a false 
impression of similarity in the output reconstruction. Besides minimizing artefacts in 
Fourier space, the soft edges of the local symmetry masks are also relevant here. Local 
symmetry is applied for all real-space pixels where the mask has values m  0, but the 
symmetrized map will be calculated as (1   m) times the original reconstruction plus m 
times the average of the corresponding voxel in all members of the group. Thereby, mask 
values of m < 1 can be used to impose local symmetry only partially. 
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For the subcomplex reconstruction, masks around each of the symmetric regions were 
created and filtered to 25 Å with mask extension to 6 pixels and a soft-edge of 10 pixels 
(Extended Data Fig. 7e). The transformation operator for the three Euler angles and the 
three translations which relate one symmetric region with the other were calculated using 
relion_localsym_mpi in real space, followed by 3D refinement using a regularization T-
value of 100. This improved the overall appearance of the map (Extended Data Fig. 7f). 
Model building 
Model building was performed using Coot45,46. All models described were built as 
polyalanine chains except FANCL (see below). 
A homology model for chicken FANCL (residues 1–373) was generated with I-TASSER47 
using Drosophila FANCL (PDB 3K1L)15 as a template. The FANCL homology model 
was rigidly fitted into the EM map in Chimera using ‘fit in map’ tool48 and then flexibly 
fitted using Jiggle fit in Coot. Densities corresponding to the ELF, URD and RING 
domains of FANCL were identified in the focused map of the base region, however, we 
were not able to orient the RING domain unambiguously in the density. The density for 
the ELF domain was well-defined in the focused map for the top region. There was only 
weak density for the URD domain and no density for the RING domain in FANCLtop 
(Extended Data Figs. 2g, 5d). The ELF domain is next to the coiled-coil helix of FANCB, 
in agreement with FANCL crosslinks to the region C-terminal of the coiled-coil helix of 
FANCB (residues 439, 441, 454 and 460) and to the FAAP100  -propeller (residues 25, 
180, 188, 262, 267 and 274). There are several crosslinks between FANCL URD-RING 
and the substrate recognition module (FANCC, FANCE and FANCF) consistent with its 
placement within the base of the complex. 
The ‘multi-body refinement map’ for the middle region, the map from T = 5 regularization, 
and the map for symmetric subcomplex were used to build the central region of FANCB-
FAAP100 de novo by placing idealized helices and strands in Coot, and refining their fits 
with the real space refine zone tool. In agreement with their role as a scaffold, FANCB and 
FAAP100 have 64 intermolecular crosslinks and they crosslink to four other subunits. 
One of the two  -propellers in the top region was built de novo using the ‘focused map’ 
for the top region and this model was used to identify a structural homologue in DALI49. 
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The  -propeller of Bardet–Biedl syndrome 1 protein (PDB 4V0N)50 was the top hit, and 
this was also a good fit for the other  -propeller. The sequence of this model was changed 
to polyalanine and used to build all four  -propellers after rigid fitting into the ‘focused 
map’ for the top or base region. 
On the basis of the crosslinking patterns and secondary structure predictions, we assigned 
one of each of the pairs of  -propellers, and one helix of each of the coiled coils to FANCB 
(N-terminal region for  -propeller and residues ~390–429 for the helix) and the other to 
FAAP100 (N-terminal region for  -propeller and residues ~461–501 for the helix). These 
assignments agree with the hydrogen deuterium exchange experiments of B-100 versus B-
L-100. The sequences of the predicted long helices of FANCB and FAAP100 were used in 
MARCOIL51,52 for assignment of heptad repeats (Extended Data Fig. 5e). Then, a 
FANCB–FAAP100 coiled-coil model was built in CCbuilder 2.053 using the advanced 
mode (Extended Data Fig. 5f). This model was then fitted into the map and refined in Coot 
using real space refinement. 
A homology model for chicken FANCG (residues 1–648) was generated in I-TASSER 
using TTC7B–hyccin complex (PDB 5DSE) and O-linked GlcNAc transferase (PDB 
1W3B) as the top two templates. The TPR region of the model (residues 153–432) was 
fitted into the focused map of the top region by rigid fitting in Chimera followed by Jiggle 
fit in Coot and refinement in Refmac. Additional helices were added towards the C-
terminal region of FANCG using Coot. 
A homology model for chicken FANCF (residues 117–343) was built in I-TASSER using 
the crystal structure of human FANCF C-terminal region (PDB 2IQC)16 as one of the 
templates. Residues 117–191 and 215–343 were rigidly fitted into the focused map for the 
base region followed by Jiggle fit and real space refinement in Coot. In addition to the 
FANCF model, several short, idealized helices were also placed into the base. A crystal 
structure for human FANCE C-terminal region (PDB 2ILR)54 was available but we could 
not fit it in the map, presumably due to conformational variation. The C terminus of 
FANCC is near FANCE (residues 155–190; Fig. 1d). 
The above models were assembled together into models for top (FANCG,  -propellers 
and long helices of FANCB and FAAP100), middle and base (FANCL, FANCF,  -
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propellers and long helices of FANCB, FAAP100, unassigned helices) regions. These 
models were then further refined in Refmac55 and Phenix iteratively56. 
The models for FANCBtop, FAAP100top, FANCB–FAAP100, FANCG and FANCLtop 
built in the complete FA core complex map were rigidly fitted into the subcomplex map 
and refined in Refmac. All models and maps were visualized and rendered in UCSF 
Chimera48 or ChimeraX57. 
Native mass spectrometry 
Native mass spectrometry experiments were carried out on a Q-Exactive Plus UHMR 
modified to facilitate the transmission of high-energy species and adapted for membrane 
proteins58–60. The FA core complex at concentration of 9.5 µM was buffer exchanged 
using Bio-Spin 6 columns (BioRad). Typically, 2–3 µl of sample in 750 mM ammonium 
acetate were injected, using a 1.2 mm outer diameter, gold-coated borosilicate capillary 
(Harvard Apparatus). The following parameters were used for protein transmission: 
capillary voltage 1.2 kV, dessolvation voltage  300 V, source fragmentation 0 V, HCD 
energy 0 V, HCD pressure 4, EMR on, C-trap entrance lens tune offset 2, injection flatopole 
8 V, inter flatopole lens 6 V, and bent flatopole 4 V. Threshold was set to 3. Data were 
analysed using Xcalibur 2.2 (Thermo Fisher), Masslynx 4.2 (Waters) and SUMMIT61. The 
formation of some of the subcomplexes observed may be the result of buffer exchange 
from 50 mM HEPES pH 8.0, ~500 mM NaCl and 1 mM TCEP into 750 mM ammonium 
acetate, which is often used in native mass spectrometry to improve resolution and generate 
subcomplexes to aid structure determination. 
HDX-MS 
Deuterium exchange reactions were initiated by diluting the complexes in D2O (99.8% 
D2O ACROS, Sigma) to give a final D2O percentage of ~95%. Deuterium labelling was 
generally carried out at 23 °C at four time points (3 s, 30 s, 300 s and 3000 s) in triplicate. 
The labelling reaction was quenched by adding chilled 2.4% v/v formic acid in 2 M 
guanidinium hydrochloride and immediately frozen in liquid nitrogen. Samples were 
stored at  80 °C before analysis. 
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The quenched samples were rapidly thawed and subjected to proteolytic cleavage using 
pepsin followed by reverse-phase high performance liquid chromatography separation. The 
proteins flowed through an Enzymate BEH immobilized pepsin column, 2.1 × 30 mm, 5 
µm (Waters) at 200 µl min 1 for 2 min, and the resulting peptides were trapped and 
desalted on a 2.1 × 5 mm C18 trap column (Acquity BEH C18 Van-guard pre-column, 1.7 
µm, Waters). Trapped peptides were eluted over 11 min using a 3–43% gradient of 
acetonitrile in 0.1% v/v formic acid at 40 µl min 1 on to a reverse phase analytical column 
(Acquity UPLC BEH C18 column 1.7 µm, 100 mm × 1 mm (Waters)). The liquid 
chromatography elute was coupled to a SYNAPT G2-Si HDMS mass spectrometer 
(Waters) and data were acquired over a m/z of 300 to 2,000, using the standard electrospray 
ionization (ESI) source with lock mass calibration using [Glu1]-fibrino peptide B (50 fmol 
µl 1). The mass spectrometer was operated in ion mobility mode, at a source temperature 
of 80 °C and a spray voltage of 2.6 kV. Spectra were collected in positive ion mode. 
Peptide identification was performed with a non-deuterated sample using MSE (Waters) to 
fragment peptides. An identical gradient of increasing acetonitrile in 0.1% v/v formic acid 
over 11 min was used and the resulting MSE data were analysed using Protein Lynx Global 
Server software (Waters) with an MS tolerance of 5 ppm. 
Mass analysis of the peptide centroids was performed using DynamX sotware (Waters). 
Only peptides with a score 6.4 were considered. All peptides (deuterated and non-
deuterated) were manually verified at every time point for the correct charge state, presence 
of overlapping peptides and correct retention time. Deuterium incorporation was not 
corrected for back-exchange and represents relative, rather than absolute changes in 
deuterium levels. Changes in H/D amide exchange in any peptide may be due to a single 
amide or several amides within that peptide. 
Crosslinking mass spectrometry of purified FA core complex 
The purified FA core complex (50 mM HEPES pH 8.0, ~500 mM NaCl and 1 mM TCEP) 
at a concentration of 7.6 µM was crosslinked with 100-fold molar ratio of 
disulfosuccinimidyl suberate (BS3) for 2 h on ice and the reaction was quenched with 50 
mM NH4HCO3 for 30 min at room temperature. The crosslinked samples were cold-
acetone precipitated and resuspended in 8 M urea and 100 mM NH4HCO3. Peptides were 
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reduced with 10 mM DTT and alkylated with 50 mM iodoacetamide. Following alkylation, 
proteins were digested with Lys-C (Pierce) at an enzyme-to-substrate ratio of 1:100 for 4 
h at 22 °C and, after diluting the urea to 1.5 M with 100 mM NH4HCO3 solution, further 
digestion with trypsin (Pierce) at an enzyme-to-substrate ratio of 1:20. 
Digested peptides were eluted from StageTips and split into two, for parallel crosslink 
enrichment by strong cation-exchange chromatography (SCX) and size exclusion 
chromatography (SEC), and were dried in a vacuum concentrator (Eppendorf). For SCX, 
eluted peptides were dissolved in mobile phase A (30% acetonitrile (v/v), 10 mM KH2PO4, 
pH 3) before strong cation exchange chromatography (100 × 2.1 mm Poly Sulfoethyl A 
column; Poly LC). The separation of the digest used a nonlinear gradient62 into mobile 
phase B (30% acetonitrile (v/v), 10 mM KH2PO4, pH 3, 1 M KCl) at a flow rate of 200 µl 
min 1. Ten 1-min fractions in the high-salt range were collected and cleaned by StageTips, 
eluted and dried for subsequent liquid chromatography with tandem mass spectrometry 
(LC-MS/MS) analysis. For peptideSEC, peptides were fractionated on an ÄKTA Pure 
system (GE Healthcare) using a Superdex Peptide 3.2/300 (GE Healthcare) at a flow rate 
of 10 µl min 1 using 30% (v/v) acetonitrile and 0.1% (v/v) trifluoroacetic acid as mobile 
phase. Five 50-µl fractions were collected and dried for subsequent LC-MS/MS analysis. 
Samples for analysis were resuspended in 0.1% v/v formic acid, 1.6% v/v acetonitrile. LC-
MS/MS analysis was conducted in duplicate for SEC fractions and triplicate for SCX 
fractions, performed on an Orbitrap Fusion Lumos Tribrid mass spectrometer (Thermo 
Fisher Scientific) coupled on-line with an Ultimate 3000 RSLCnano system (Dionex, 
Thermo Fisher Scientific). The sample was separated and ionized by a 50 cm EASY-Spray 
column (Thermo Fisher Scientific). Mobile phase A consisted of 0.1% (v/v) formic acid 
and mobile phase B of 80% v/v acetonitrile with 0.1% v/v formic acid. Flow-rate of 0.3  l 
min 1 using gradients optimized for each chromatographic fraction from offline 
fractionation ranging from 2% mobile phase B to 45% mobile phase B over 90 min, 
followed by a linear increase to 55% and 95% mobile phase B in 2.5 min, respectively. 
The MS data were acquired in data-dependent mode using the top-speed setting with a 
three second cycle time. For every cycle, the full scan mass spectrum was recorded in the 
Orbitrap at a resolution of 120,000 in the range of 400 to 1,600 m/z. Ions with a precursor 
charge state between 3+ and 7+ were isolated and fragmented. Fragmentation by higher-
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energy collisional dissociation (HCD) employed a decision tree logic with optimized 
collision energies63. The fragmentation spectra were then recorded in the Orbitrap with a 
resolution of 50,000. Dynamic exclusion was enabled with single repeat count and 60-s 
exclusion duration. 
A recalibration of the precursor m/z was conducted based on high-confidence (<1% false 
discovert rate (FDR)) linear peptide identifications64. The recalibrated peak lists were 
searched against the sequences and the reversed sequences (as decoys) of crosslinked 
peptides using the Xi software suite (v.1.6.746)65 (https://github.com/Rappsilber-
Laboratory/XiSearch) for identification. The following parameters were applied for the 
search: MS1 accuracy = 3 ppm; MS2 accuracy = 10 ppm; enzyme = trypsin (with full 
tryptic specificity) allowing up to four missed cleavages; crosslinker = BS3 with an 
assumed reaction specificity for lysine, serine, threonine, tyrosine and protein N termini); 
fixed modifications = carbamidomethylation on cysteine; variable modifications = 
oxidation on methionine, hydrolyzed/aminolyzed BS3 from reaction with ammonia or 
water on a free crosslinker end. The identified candidates were filtered to 1% FDR on link 
level using XiFDR v.1.1.26.5866. 
Pull down assay 
The purified subcomplexes A-G-B-L-100 and C-E-F (Strep II tag cleaved by 3C protease) 
were mixed in a 1:1 molar ratio at concentrations of 1.4 µM each, for 1 h at 4 °C. A 20-µl 
reaction was incubated with 15 µl of Strep-Tactin beads (GE healthcare) equilibrated in 50 
mM HEPES pH 8.0, 300 mM NaCl and 1 mM TCEP. The flow through was collected 
(unbound fraction) and the beads were washed three times with equilibration buffer. The 
unbound and bound fractions were analysed on SDS–PAGE. 
Data availability 
Cryo-EM maps generated during this study have been deposited in the Electron 
Microscopy Data Bank with accession codes EMD-10290 (FA core complex consensus), 
EMD-10291 (focused classification top region), EMD-10292 (focused classification 
middle region), EMD-10293 (focused classification base region) and EMD-10294 
(subcomplex). Models generated during this study have been deposited in the protein 
databank (PDB) with accession codes 6SRI (FA core complex) and 6SRS (subcomplex). 
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Native mass spectrometry data are available from figshare at 
https://doi.org/10.6084/m9.figshare.9692192. Crosslinking mass spectrometry data have 
been deposited in the PRIDE database with accession code PXD014282. All other data are 
available from the authors upon reasonable request. 
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Extended Data Fig. 1 | Recombinant FA core complex activity. a, Ubiquitination 
assay analysed by western blot with HA antibody to detect HA-tagged ubiquitin. The 
migration positions of monoubiquitinated FANCD2 and FANCI are indicated but FANCI 
is not substantially modified. b, Ubiquitination assay analysed by Coomassie-stained 
SDS–PAGE to show specific monoubiquitination of FANCD2 K563 by recombinant FA 
core complex. Wild type (WT), FANCD2(K563R) and FANCI(K525R) (KR) were 
analysed. A native FA core complex purified from chicken DT40 cells monoubiquinates 
FANCD2 but does not efficiently monoubiquitinate FANCI6. Therefore, the purified 
recombinant complex faithfully recapitulates the properties of the native chicken 
complex. Notably, a purified human complex also did not efficiently monoubiquitinate 
FANCI, although it did efficiently monoubiquitinate FANCD211. The asymmetry in the 
FA core complex (see below) reflects this asymmetry in its activity on FANCI–
FANCD2. An additional factor or post-translational modification may be required for 
activation of FANCI monoubiquitination. The ubiquitination assays were repeated at 
least two times independently with similar results. For gel source data, see 
Supplementary Fig. 1. 
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Extended Data Fig. 2 | Cryo-EM reconstruction of FA core complex, multi-body 
refinement and assessment of 3D reconstructions after focused refinement. a, 
Representative raw micrograph of FA core complex. b, Overall 3D reconstruction of the 
FA core complex. c, Angular distribution density plot of particles used in the 3D 
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reconstruction of the FA core complex. Every point is a particle orientation and the 
colour scale represents the normalized density of views around this point. The colour 
scale runs from 0 (low, blue) to 0.00026 (high, red). The efficiency of orientation 
distribution67, EOD, was 0.79. d, Estimated local resolution map for FA core complex. e, 
FSC plot for gold standard refinement. f, Multibody refinement of the FA core complex 
using three masks (body 1, body 2 and body 3) shown in purple, pink and cyan, 
respectively. The motions are shown in Supplementary Videos 1 and 2. g, Local 
resolution maps for reconstructions of top, middle and base regions of FA core complex. 
The middle region did not substantially change between multi-body refinement and 
particle subtraction followed by focused classification. The resolution of the base and top 
regions improved after particle subtraction and focused classification and refinement. h, 
FSC plot for gold standard refinements. i, Representative density for  -strand and  -
helical regions. FANCB–FAAP100 is in the middle region which is better defined than 
more peripheral regions, including FANCF. 
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Extended Data Fig. 3 | Subunit assignment and arrangement in FA core complex. a–
c, Complexes lacking specific subunits were purified and analysed by cryo-EM. a, Major 
2D class averages identified for subcomplexes, compared with those from FA core 
complex (A-G-B-L-100-C-E-F). Cartoons are shown to depict the subunits visible in the 
class averages. The symmetric subcomplex identified in the FA core complex preparation 
is indicated (sym). The A-G-B-L-100 complex (lacking the substrate recognition module) 
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has similar symmetric 2D classes. Native mass spectrometry revealed a non-uniform 
subunit stoichiometry. Thus it is likely that the asymmetric assembly represents the 
complete FA core complex, while the symmetric structure is a subcomplex that co-
purifies with the intact complex. The 2D class average of a complex lacking FANCA (G-
B-L-100-C-E-F) appeared similar to the complete FA core complex with no obvious 
missing density. FANCG is likely the partially disordered arm that extends from the 
central part of the complex since this was missing when FANCG was not present in the 
complex. b, Coomassie-stained SDS–PAGE analysis of purified subcomplexes. Asterisks 
indicate contaminant proteins. FANCA did not co-purify with the A-B-L-100 complex 
but its migration position is indicated on the gel. The purifications were repeated at least 
two times independently with similar results. For gel source data, see Supplementary Fig. 
1. c, Cartoon of FA core complex with subunits labelled. d, Native mass spectrum of 
recombinant FA core complex showing masses and subunit composition of assigned peak 
series. The FA core complex dissociated into subcomplexes during ionization and these 
species were detected by mass spectrometry. Computational analyses then revealed the 
proteins present in each of the peaks. The standard deviation in fitting the identified 
peaks to the charge series is given as the ± error in the measured mass for a given single 
measurement. This is the error in the fit and not the error in the mass measurement, which 
is probably an order of magnitude higher due to, for instance, solvation or adduct effects, 
or heterogeneous post-translational modifications. Hence, the error gives a rough measure 
of the accuracy of peak assignment, which is impacted by the broadness, symmetry and 
signal-to-noise ratio of each peak. e, Molecular masses of FA core complex subunits. The 
expected and measured masses are given, along with phosphorylation sites detected by 
mass spectrometry. Native mass spectrometry was repeated three times with similar 
results. 
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Extended Data Fig. 4 | Crosslinking mass spectrometry. a, Crosslinking mass 
spectrometry revealed 834 crosslinks (1% FDR) between residues that are in close 
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proximity. Intermolecular crosslinks are coloured in green; intramolecular crosslinks, red; 
predicted  -helices, orange; predicted  -strands, purple. Asterisks on FANCB mark 
missense mutations from the Fanconi Anaemia Mutation Database 
(http://www2.rockefeller.edu/fanconi/) including L43S in a predicted  -strand, P230S at 
the N terminus of a predicted helix, and L329P in the middle of a predicted  -strand, all 
in the  -propeller; and L676P, which is predicted to disrupt an  -helix in the C-terminal 
dimerization domain. b–d, Validation of crosslinking of FA core complex. Crosslinks 
were mapped onto a homology model of chicken FANCL (b), human FANCF (c) and 
human FANCE (d). All intramolecular crosslinks within a domain are consistent with the 
maximum crosslinker length (30 Å between the two C ). Crosslinks between the 
domains in FANCL are not consistent with the domain arrangement in the crystal 
structure of FANCL because there is flexibility or changes in the orientation between the 
domains in the FA core complex. There are two different conformations of FANCL in the 
structure: FANCLbase is fully ordered, whereas only the ELF domain is visible in 
FANCLtop. Mapping the crosslinks onto FANCL from the base (constrained, with all 
three domains visible) reveals that the distances for some crosslinks between domains are 
too large to be consistent with the FANCL conformation in the base. By contrast, for 
FANCL in the top, where only the ELF domain is ordered, the URD and RING domains 
are likely to be conformationally flexible. Since the URD and RING domains cannot be 
modelled for FANCLtop, it is not possible to validate these interdomain crosslinks. 
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Extended Data Fig. 5 | Assessment of model fit in maps and modelling of coiled coils. 
a–c, FSC plots of maps versus model for top (a), middle (b) and base (c) regions. d, Low-
resolution cryo-EM map of FA core complex (transparent surface) with models placed in 
the map. Asterisks represent density that was not visible at high resolution and was not 
interpreted. This may represent FANCA and additional parts of the substrate recognition 
module. e, MARCOIL51 prediction for the best heptad phase in the long helices of 
FANCB and FAAP100. f, Predicted coiled-coil model by CCbuilder 2.053 for the 
FANCB and FAAP100 long helices. Crosslinks detected for these helices in the FA core 
complex crosslinking mass spectrometry are indicated with blue lines. 
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Extended Data Fig. 6 | HDX-MS on FANCB and FAAP100. a–d, Difference plots for 
FANCB showing peptides that are protected (negative) or exposed (positive) upon 
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binding of additional subunit(s) for B-L-100 vs B-100 (a), G-B-L-100 vs B-L-100 (b), A-
G-B-L-100 vs G-B-L-100 (c) and FA core complex vs. G-B-L-100 (d). Exchange of 
hydrogens in FANCB residues 429–448 was protected after interaction with FANCL, 
consistent with FANCL being located next to the coiled coil. e–h, Difference plots for 
FAAP100 showing peptides that are protected (negative) or exposed (positive) upon 
binding of additional subunit(s) for B-L-100 vs B-100 (e), G-B-L-100 vs B-L-100 (f), A-
G-B-L-100 vs. G-B-L-100 (g) and FA core complex vs G-B-L-100 (h). Exchange of 
hydrogens in FAAP100 residues 448–464 was protected after interaction with FANCL, 
consistent with FANCL being located next to the coiled coil. For difference plots, 
triplicate data from four independent colour-coded time points are shown. The 
significance threshold is indicated by dashed lines. Grey shading indicates the standard 
deviation of all charge states and replicates per peptide. Sequence coverage is shown in 
the Supplementary Information. 
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Extended Data Fig. 7 | 3D reconstruction of symmetric FA subcomplex and local 
symmetry refinement. a, Overall 3D reconstruction of the symmetric FA subcomplex. b, 
Angular distribution plot of particles used in the 3D reconstruction of the symmetric FA 
subcomplex. Every point is a particle orientation and the colour scale represents the 
normalized density of views around this point. The colour scale runs from 0 (low, blue) 
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to 0.00026 (high, red). The efficiency of orientation distribution67, EOD, was 0.65. c, 
Estimated local resolution map for symmetric FA subcomplex. d, FSC plot for gold 
standard refinement. e, Local symmetry pipeline for reconstruction of the symmetric FA 
subcomplex (see Methods). This reconstruction could not be improved with C2 
symmetry, probably because of local flexibility. f, FSC plot for gold standard refinement 
shown for the subcomplex reconstruction before and after local symmetry refinement. 
The circular panels show representative densities before and after local symmetry 
refinement. 
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Extended Data Fig. 8 | Model for FA subcomplex. a, Model of FA subcomplex shown 
as cartoon representations of subunits fit into the cryo-EM map. b, Model of FA 
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subcomplex shown as a surface representation of the combined models. Two views are 
shown down the two-fold symmetric axis. c, Comparison of FA subcomplex and 
complete FA core complex in the same orientations. Both models are shown in cartoon 
representation. Subunits are coloured as in Fig. 1e. d, Modelling of a fully symmetric FA 
core complex containing two copies of every subunit. Left, the second copy of FANCG 
(cartoon) from the FA subcomplex was modelled onto the structure of the FA core 
complex (surface representation). This second FANCG clashes with the FANCB b-
propeller in the base (asterisks). Thus, it is likely that upon binding of the substrate 
recognition module, rearrangement of the b-propellers of FANCB and FAAP100 
prevents binding of a second copy of FANCG. (Right) A second copy of substrate 
recognition module (FANCC–FANCE–FANCF; cartoon) is modelled in the top region of 
the FA core complex by combining the models of FANCC–FANCE–FANCF and 
FANCLbase from FA core complex followed by superimposing FANCLbase on FANCLtop. 
There is a clash (asterisks) between the modelled FANCL (cartoon) and FAAP100 b-
propeller (surface representation). These data suggest that a fully symmetric complex 
does not readily form. In agreement with this, there was no evidence for any classes 
containing two copies of C-E-F in any of our EM analyses of the FA core complex. e, f, 
The symmetric FA subcomplex (A-G-B-L-100) does not readily associate with purified 
substrate recognition module (C-E-F) to form the asymmetric FA core complex. e, The 
2D class averages of A-G-B-L-100 mixed with C-E-F compared with complete FA core 
complex, FA subcomplex and A-G-B-L-100 subcomplex. A-G-B-L-100 was mixed with 
C-E-F in molar ratios of 1:1 and 1:2 for 1 h at 4 °C before cryo-plunging. Only the 
symmetric A-G-B-L-100 subcomplex was observed and there was no additional density 
for C-E-F. Panels for FA core complex, subcomplex and A-G-B-L-100 are replicated 
from Extended Data Fig. 3a. f, Pull-down assay of C-E-F using tagged A-G-B-L-100 
(Strep II tagged). Left, the Coomassie Blue-stained gel of purified C-E-F (with Strep II 
tag, after 3C cleavage of tag and after removal of 3C protease). Tagged A-G-B-L-100 
was immobilized on Strep-Tactin resin and incubated with purified C-E-F at a 1:1 molar 
ratio. After washing, only a small amount of C-E-F remains bound to the beads. Negative 
controls (A-G-B-L-100 only and C-E-F only) are shown in the middle panel. Asterisk 
indicates a contaminant protein. The pulldown experiment was repeated two times 
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independently with similar results. Since C-E-F does not efficiently bind A-G-B-L-100, 
these experiments suggest that these species are unlikely to be in equilibrium in solution. 
Previous genetic and biochemical data show that FANCC, FANCE and FANCF are 
important for monoubiquitination of the FANCI–FANCD2 substrate. Together, these 
data provide evidence that the asymmetric complex is the relevant, functional, 
physiological entity. 
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Extended Data Fig. 9 | Structural comparison of E3 ligases. a, There is a strong 
precedence for dimerization of RING/U-box domain E3 ubiquitin ligases68–70. RING/U-
box E3 s exist both as homo- and heterodimeric complexes, for example, Rad18–Rad18, 
CHIP–CHIP, RNF8–RNF8, BRCA1–BARD1, RING1b–BMI1 and Hdm2–Hdmx17–21,71. 
Structures of homo- and heterodimeric RING/U-box E3 ligases are shown here with the 
RING/U-box in orange. Surprisingly, these E3 s display functional and structural 
asymmetry: in all the dimers listed above, only one protomer binds to an E2 enzyme. The 
homodimeric CHIP E3 ligase has a strikingly asymmetric structure that clearly 
demonstrates why only one U-box binds E2 enzyme19. The FANCL RING subunit is also 
an asymmetric dimer within the FA core complex and it is possible that only one of these 
binds E2. However, unlike the smaller E3 s, the FANCL RING fingers are not near each 
other. Together, this suggests that asymmetric dimerization may be a general feature of 
RING E3s. b, Comparison of FA core complex with cullin–RING ubiquitin ligases 
(CRLs). Many large complexes are predominantly helical suggesting that a-helices are 
commonly used as building blocks for complexes. In addition, b-propellers often mediate 
protein–protein interactions. The CRL complexes and FA core complex are long and 
extended with substrate-recognition (green), scaffold (yellow) and RING (orange) 
subunits residing in three different regions of the structure. However, the structural 
details of these complexes differ. Interestingly, the activities of some multisubunit RING-
containing E3 ligases including APC/C and CRL complexes are stimulated by 
dimerization22,23. Thus, dimerization may underpin physiological ubiquitination activity 
in many E3 ligases. c, d, Ubiquitin discharge assay, in which free lysine is used instead of 
the FANCI–FANCD2 substrate. In these experiments, the FA core complex is incubated 
with E1, E2, ubiquitin and free lysine. If FANCL is active without a substrate, ubiquitin 
will be conjugated to lysine, resulting in a shift in its molecular weight; however, if 
substrate binding is required to activate the E3 ligase activity (for example, through 
allosteric changes), this will not occur. Coomassie gels of reaction products were run in 
non-reducing (c) and reducing (100 mM DTT) conditions (d). Ubiquitin is transferred to 
free lysine as shown by the increase in molecular weight of ubiquitin as well as a 
decrease in intensity of the E2–ubiquitin band when compared to the lane containing no 
free lysine. Thus, substrate binding is not required for activity. Reducing conditions do 
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not eliminate the UBE2T–ubiquitin conjugate, as previously shown72. Additionally, DNA 
is not required for FA core complex E3 ligase activity on free lysines, suggesting that 
DNA activates the substrate, not the E3. The ubiquitin discharge assays were repeated 
three times independently with similar results (c, d). e, Distributions of patient mutations 
are indicated on the FA core complex by heat map colouring of subunits and in 
percentage. f, Ubiquitination assay using several subcomplexes (Extended Data Fig. 3b) 
and the full FA core complex, analysed by western blot with HA antibody to detect HA-
tagged ubiquitin. The migration positions of monoubiquitinated FANCD2 and FANCI 
are indicated but FANCI is not substantially modified, as in Extended Data Fig. 1a. All 
complexes have similar activities but isolated FANCL is less active. This assay was 
repeated at least two times independently with similar results. For gel source data, see  
 
